Looking ahead to 2025, Globus Medical has provided guidance that reflects both its standalone operations and the impact of its recent acquisition of Nevro Corp (NYSE:NVRO). The company expects net ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Looking ahead to 2025, Globus Medical has provided guidance that reflects both its standalone operations and the impact of its recent acquisition of Nevro Corp (NYSE:NVRO). The company expects net ...

Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even if ...

Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales ...

The firm's analysis supports the company's ongoing strategy, particularly in the wake of its acquisition of Nevro Corp (NYSE:NVRO). Canaccord Genuity expressed confidence in Globus Medical's ...

Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group ...

BTIG analysts have downgraded Globus Medical (NYSE:GMED ... The analysts also project a meaningful sales disruption within Nevro to offer some cushion, potentially lowering the bar for Spine.

Mr. Thornal will join the company July 1. He was previously CEO and president of Nevro, which was acquired by Globus Medical in April. He also worked at Hologic for nine years and held several ...

Thornal was president and CEO of spinal cord stimulation company Nevro from April 2023 until it was acquired by Globus Medical last month for about $250 million. Before that, he was group president of ...